Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Antihypertensive Agents"" wg kryterium: Temat


Starter badań:

Tytuł:
Valorization of Chicken Slaughterhouse Byproducts to Obtain Antihypertensive Peptides.
Autorzy:
Bravo FI; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
Calvo E; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
López-Villalba RA; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
Torres-Fuentes C; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
Muguerza B; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
García-Ruiz A; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
Morales D; Nutrigenomics Research Group, Department of Biochemistry and Biotechnology, Universitat Rovira i Virgili, 43007 Tarragona, Spain.
Pokaż więcej
Źródło:
Nutrients [Nutrients] 2023 Jan 15; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 15.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/chemistry
Hypertension*/drug therapy
Animals ; Angiotensin-Converting Enzyme Inhibitors/metabolism ; Chickens/metabolism ; Abattoirs ; Protein Hydrolysates/pharmacology ; Peptides/pharmacology
Czasopismo naukowe
Tytuł:
Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
Autorzy:
Smith SM; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida Gainesville FL.; Division of Cardiovascular Medicine, Department of Medicine, College of Medicine University of Florida Gainesville FL.; Center for Integrative Cardiovascular and Metabolic Disease University of Florida Gainesville FL.
Winterstein AG; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida Gainesville FL.
Gurka MJ; Department of Health Outcomes and Biomedical Informatics, College of Medicine University of Florida Gainesville FL.
Walsh MG; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida Gainesville FL.
Keshwani S; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida Gainesville FL.
Libby AM; Department of Emergency Medicine, School of Medicine University of Colorado Denver Aurora CO.
Hogan WR; Department of Pharmaceutical Outcomes and Policy, College of Pharmacy University of Florida Gainesville FL.
Pepine CJ; Division of Cardiovascular Medicine, Department of Medicine, College of Medicine University of Florida Gainesville FL.
Cooper-DeHoff RM; Division of Cardiovascular Medicine, Department of Medicine, College of Medicine University of Florida Gainesville FL.; Center for Integrative Cardiovascular and Metabolic Disease University of Florida Gainesville FL.; Department of Pharmacotherapy and Translational Research, College of Pharmacy University of Florida Gainesville FL.
Pokaż więcej
Źródło:
Journal of the American Heart Association [J Am Heart Assoc] 2023 Jan 03; Vol. 12 (1), pp. e026652. Date of Electronic Publication: 2022 Dec 24.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/epidemiology
Humans ; Female ; Aged ; United States/epidemiology ; Middle Aged ; Male ; Medicare ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Adrenergic beta-Antagonists/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use
Czasopismo naukowe
Tytuł:
Evaluation of vasodilatory effect and antihypertensive effect of chrysin through in vitro and sub-chronic in vivo study.
Autorzy:
Tew WY; College of Pharmacy, Fujian University of Traditional Chinese Medicine, 1 Qiuyang Road, Shangjie, Minhou, Fuzhou 350122, Fujian, China; Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Tan CS; Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Yan CS; Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Loh HW; Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia.
Wen X; College of Pharmacy, Fujian University of Traditional Chinese Medicine, 1 Qiuyang Road, Shangjie, Minhou, Fuzhou 350122, Fujian, China.
Wei X; College of Pharmacy, Fujian University of Traditional Chinese Medicine, 1 Qiuyang Road, Shangjie, Minhou, Fuzhou 350122, Fujian, China. Electronic address: .
Yam MF; College of Pharmacy, Fujian University of Traditional Chinese Medicine, 1 Qiuyang Road, Shangjie, Minhou, Fuzhou 350122, Fujian, China; Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia. Electronic address: .
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2023 Jan; Vol. 157, pp. 114020. Date of Electronic Publication: 2022 Dec 02.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/metabolism
Vasodilation*
Animals ; Rats ; Aorta, Thoracic ; Calcium Channels/metabolism ; Cyclic GMP/metabolism ; Endothelium, Vascular ; Rats, Inbred SHR ; Receptors, Adrenergic, beta/metabolism ; Vasodilator Agents/pharmacology
Czasopismo naukowe
Tytuł:
Home Blood Pressure Self-monitoring plus Self-titration of Antihypertensive Medication for Poorly Controlled Hypertension in Primary Care: the ADAMPA Randomized Clinical Trial.
Autorzy:
Martínez-Ibáñez P; INCLIVA Health Research Institute, Valencia, Spain.; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.
Marco-Moreno I; INCLIVA Health Research Institute, Valencia, Spain.; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.
Peiró S; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Department of Statistics and Operations Research, Universidad de Valencia, Valencia, Spain.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.
Martínez-Ibáñez L; INCLIVA Health Research Institute, Valencia, Spain.
Barreira-Franch I; INCLIVA Health Research Institute, Valencia, Spain.
Bellot-Pujalte L; INCLIVA Health Research Institute, Valencia, Spain.
Avelino-Hidalgo E; INCLIVA Health Research Institute, Valencia, Spain.
Escrig-Veses M; INCLIVA Health Research Institute, Valencia, Spain.
Bóveda-García M; INCLIVA Health Research Institute, Valencia, Spain.
Calleja-Del-Ser M; INCLIVA Health Research Institute, Valencia, Spain.
Ferrero-Gregori A; INCLIVA Health Research Institute, Valencia, Spain.; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.
Iftimi AA; INCLIVA Health Research Institute, Valencia, Spain.; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Department of Statistics and Operations Research, Universidad de Valencia, Valencia, Spain.
Hurtado I; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, Spain.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.
García-Sempere A; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, Spain.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.
Rodríguez-Bernal CL; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, Spain.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain.
Giménez-Loreiro M; INCLIVA Health Research Institute, Valencia, Spain.
Sanfélix-Gimeno G; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain. sanfelix_.; Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, Spain. sanfelix_.; Research Network On Chronicity, Primary Care, and Health Promotion (RICAPPS), Valencia, Spain. sanfelix_.
Sanfélix-Genovés J; INCLIVA Health Research Institute, Valencia, Spain.; Health Services Research Unit, FISABIO, Catalunya Av. 21, 46020, Valencia, Spain.; Network for Health Services Research in Chronic Diseases (REDISSEC), Valencia, Spain.
Pokaż więcej
Corporate Authors:
ADAMPA research group
Źródło:
Journal of general internal medicine [J Gen Intern Med] 2023 Jan; Vol. 38 (1), pp. 81-89. Date of Electronic Publication: 2022 Oct 11.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Humans ; Blood Pressure ; Quality of Life ; Primary Health Care
Czasopismo naukowe
Tytuł:
Prescribing pattern of anti-hypertensive medications among hypertensive outpatients at selected hospitals of South Gondar Zone, Amhara, Ethiopia: a hospital based cross sectional study.
Autorzy:
Yazie TS; Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Amhara, Ethiopia.
Yimer YS; Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Amhara, Ethiopia. .
Belete AM; Department of Medicine, College of Medicine and Health Sciences, Debre Berhan University, Debre Berhan, Amhara, Ethiopia.
Desta GT; Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Tabor University, Debre Tabor, Amhara, Ethiopia.
Pokaż więcej
Źródło:
BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2022 Dec 30; Vol. 23 (1), pp. 97. Date of Electronic Publication: 2022 Dec 30.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Humans ; Cross-Sectional Studies ; Ethiopia ; Outpatients ; Blood Pressure ; Hospitals
Czasopismo naukowe
Tytuł:
Food Peptides, Gut Microbiota Modulation, and Antihypertensive Effects.
Autorzy:
Tsafack PB; Nutrition and Functional Food, School of Biosciences and Veterinary Medicine, University of Camerino, Via A. D'Accorso, 16, 62032 Camerino, Italy.
Li C; School of Life Science, Shanxi University, Taiyuan 030006, China.
Tsopmo A; Food Science and Nutrition Program, Department of Chemistry, Carleton University, Ottawa, ON K1S 5B6, Canada.; Institute of Biochemistry, Carleton University, Ottawa, ON K1S 5B6, Canada.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Dec 12; Vol. 27 (24). Date of Electronic Publication: 2022 Dec 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Gastrointestinal Microbiome*
Animals ; Humans ; Prebiotics ; Peptides/pharmacology ; Peptides/therapeutic use ; Inflammation/drug therapy
Czasopismo naukowe
Tytuł:
Clinical characteristics do not reliably identify non-adherence in patients with uncontrolled hypertension.
Autorzy:
Groenland EH; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, The Netherlands.
Dasgupta I; Renal Unit, Heartlands Hospital, Birmingham and Warwick Medical School, University of Warwick, Coventry, UK.
Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, The Netherlands.
van der Elst KCM; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, The Netherlands.
Lorde N; Department of Clinical Chemistry, Immunology and Toxicology, Heartlands Hospital University Hospitals Birmingham, UK.
Lawson AJ; Department of Clinical Chemistry, Immunology and Toxicology, Heartlands Hospital University Hospitals Birmingham, UK.
Bots ML; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Spiering W; Department of Vascular Medicine, University Medical Center Utrecht, Utrecht University, The Netherlands.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2022 Dec; Vol. 31 (1), pp. 178-186.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/diagnosis
Humans ; Medication Adherence ; Predictive Value of Tests
Czasopismo naukowe
Tytuł:
Impact of drug adherence on blood pressure response to alcohol-mediated renal denervation.
Autorzy:
Persu A; Division of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Maes F; Division of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Toennes SW; Institute of Legal Medicine, Goethe University, Frankfurt, Germany.
Ritscher S; Institute of Legal Medicine, Goethe University, Frankfurt, Germany.
Georges C; Division of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Wallemacq P; Clinical Chemistry Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Haratani N; Ablative Solutions, Inc., San Jose, CA, USA.
Parise H; Ablative Solutions, Inc., San Jose, CA, USA.
Fischell TA; Ablative Solutions, Inc., San Jose, CA, USA.
Lauder L; Department of Internal Medicine III, Saarland University Medical Center, Homburg, Germany.
Mahfoud F; Department of Internal Medicine III, Saarland University Medical Center, Homburg, Germany.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2022 Dec; Vol. 31 (1), pp. 109-117.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/surgery
Aged ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory/methods ; Denervation/methods ; Female ; Humans ; Kidney ; Male ; Medication Adherence ; Middle Aged ; Sympathectomy/methods ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Single-pill combinations, hypertension control and clinical outcomes: potential, pitfalls and solutions.
Autorzy:
Egan BM; American Medical Association, Greenville, SC, USA.
Kjeldsen SE; Departments of Cardiology and Nephrology, University of Oslo, Ullevaal Hospital, Oslo, Norway.
Narkiewicz K; Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland.
Kreutz R; Charité - Universitätsmedizin Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany.
Burnier M; Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2022 Dec; Vol. 31 (1), pp. 164-168.
Typ publikacji:
Editorial
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/prevention & control
Blood Pressure/drug effects ; Drug Combinations ; Humans ; Tablets
Opinia redakcyjna
Tytuł:
Sustained release of brimonidine from .
Autorzy:
Zhao Y; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Huang C; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Zhang Z; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Hong J; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Xu J; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.
Sun X; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China.
Sun J; Eye Institute and Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.; NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai, China.; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 613-623.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents/*pharmacology
Brimonidine Tartrate/*pharmacology
Drug Delivery Systems/*methods
Glaucoma/*pathology
Animals ; Antihypertensive Agents/administration & dosage ; Antihypertensive Agents/adverse effects ; Brimonidine Tartrate/administration & dosage ; Brimonidine Tartrate/adverse effects ; Cell Line ; Delayed-Action Preparations ; Dose-Response Relationship, Drug ; Drug Implants ; Drug Liberation ; Humans ; Intraocular Pressure/drug effects ; Ophthalmic Solutions ; Rabbits ; Random Allocation ; Silicones/chemistry
Czasopismo naukowe
Tytuł:
Do antihypertensive medications effect the mandibular cortical bone thickness? A study using cone beam computed tomography images.
Autorzy:
Spenrath B; Department of Oral and Maxillofacial Surgery, University of Rochester, Eastman Institute for Oral Health, Rochester, NY, USA.
Kolokythas A; Department of Oral and Maxillofacial Surgery, University of Rochester, Eastman Institute for Oral Health, Rochester, NY, USA. Electronic address: Antonia_.
Pokaż więcej
Źródło:
Oral surgery, oral medicine, oral pathology and oral radiology [Oral Surg Oral Med Oral Pathol Oral Radiol] 2022 Dec; Vol. 134 (6), pp. 687-694. Date of Electronic Publication: 2022 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Cone-Beam Computed Tomography*
Cortical Bone*/diagnostic imaging
Antihypertensive Agents*/adverse effects
Antihypertensive Agents*/therapeutic use
Mandible*/diagnostic imaging
Aged ; Female ; Humans ; Male ; Middle Aged ; Cross-Sectional Studies ; Retrospective Studies ; Adult
Czasopismo naukowe
Tytuł:
The impact of renal denervation procedure on use of antihypertensive drugs in the real-life setting.
Autorzy:
Rea F; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Morabito G; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Savaré L; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; MOX - Laboratory for Modeling and Scientific Computing, Department of Mathematics, Politecnico di Milano, Milan, Italy.; CHDS - Center for Health data Science, Human Technopole, Milan, Italy.
Corrao G; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Laboratory of Healthcare Research and Pharmacoepidemiology, Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Mancia G; University of Milano-Bicocca (Emeritus Professor), Milan, Italy.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2022 Dec; Vol. 31 (1), pp. 245-253.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Hypertension*/surgery
Aged ; Angiotensin Receptor Antagonists/therapeutic use ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Calcium Channel Blockers/therapeutic use ; Denervation/methods ; Diuretics/therapeutic use ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł:
Rapid decrease in eGFR with concomitant use of tyrosine kinase inhibitors and renin-aldosterone-angiotensin system inhibitors in patients with chronic myelogenous leukemia.
Autorzy:
Tsuda M; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Hirata A; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Tokunaga S; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Masuda T; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Haji S; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Kimura D; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Nojiri C; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Nakashima Y; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. .
Shiratsuchi M; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.; Department of Hematology, Iizuka Hospital, Iizuka, Japan.
Kato K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Miyamoto T; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Akashi K; Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nakashima N; Medical Information Center, Kyushu University Hospital, Fukuoka, Japan.
Ogawa Y; Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Pokaż więcej
Źródło:
International journal of hematology [Int J Hematol] 2022 Dec; Vol. 116 (6), pp. 863-870. Date of Electronic Publication: 2022 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/complications
Humans ; Imatinib Mesylate/adverse effects ; Glomerular Filtration Rate ; Aldosterone/pharmacology ; Aldosterone/therapeutic use ; Renin/pharmacology ; Renin/therapeutic use ; Retrospective Studies ; Protein Kinase Inhibitors/adverse effects ; Enzyme Inhibitors/therapeutic use ; Angiotensins/pharmacology ; Angiotensins/therapeutic use
Czasopismo naukowe
Tytuł:
Clinical characteristics and management of hemodialysis patients with pre-dialysis hypertension: a multicenter observational study.
Autorzy:
Liang Y; Department of Nephrology, Peking University People's Hospital, Beijing, China.
Gan L; Department of Nephrology, Peking University People's Hospital, Beijing, China.
Shen Y; Department of Nephrology, Miyun Hospital, Beijing, China.
Li W; Department of Nephrology, Shijingshan Hospital, Beijing, China.
Zhang D; Department of Nephrology, Peking University International Hospital, Beijing, China.
Li Z; Department of Nephrology, Capital Medical University Affiliated Luhe Hospital, Beijing, China.
Ren J; Department of Nephrology, Aviation General Hospital, Beijing, China.
Xu M; Department of Nephrology, Zhanlanlu Hospital of Xicheng District, Beijing, China.
Zhao X; Jiaozhou Bethune Blood Purification Center, Shandong, China.
Ma Y; Department of Nephrology, Beijing Boai Hospital, China Rehabilitation Research Center, Beijing, China.
Zuo L; Department of Nephrology, Peking University People's Hospital, Beijing, China.
Wang M; Department of Nephrology, Peking University People's Hospital, Beijing, China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2022 Dec; Vol. 44 (1), pp. 1811-1818.
Typ publikacji:
Multicenter Study; Observational Study; Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Antihypertensive Agents*/pharmacology
Hypertension*/etiology
Hypertension*/complications
Humans ; Dialysis ; Renal Dialysis/adverse effects ; Blood Pressure ; Hemoglobins
Czasopismo naukowe
Tytuł:
Psychological determinants of drug adherence and severity of hypertension in patients with apparently treatment-resistant vs. controlled hypertension.
Autorzy:
Georges CMG; Department of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Ritscher S; Institute of Legal Medicine, Department of Forensic Toxicology, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt/Main, Germany.
Pappaccogli M; Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy.
Petit G; Adult Psychiatry Department and Institute of Neuroscience, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Lopez-Sublet M; Department of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.; Department of Internal Medicine, ESH Hypertension Excellence Center, CHU Avicenne AP-HP, Bobigny, France Bobigny.
Bapolisi A; Adult Psychiatry Department and Institute of Neuroscience, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.; Université Catholique de Bukavu and Hôpital Provincial Général de Bukavu, Bukavu, Democratic Republic of Congo.
Di Monaco S; Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy.
Wallemacq P; Clinical Chemistry Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium.; Center for Toxicology and Applied Pharmacology, Université Catholique de Louvain, Brussels, Belgium.
Rabbia F; Department of Medical Sciences, Internal Medicine and Hypertension Division, AOU Città della Salute e della Scienza, Turin, Italy.
Toennes SW; Institute of Legal Medicine, Department of Forensic Toxicology, University Hospital Frankfurt, Goethe-University Frankfurt, Frankfurt/Main, Germany.
de Timary P; Adult Psychiatry Department and Institute of Neuroscience, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Persu A; Department of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.; Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Pokaż więcej
Źródło:
Blood pressure [Blood Press] 2022 Dec; Vol. 31 (1), pp. 169-177.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Antihypertensive Agents*/therapeutic use
Hypertension*
Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Humans ; Medication Adherence ; Pilot Projects
Czasopismo naukowe
Tytuł:
Effects of the July 2018 worldwide valsartan recall and shortage on global trends in antihypertensive medication use: a time-series analysis in 83 countries.
Autorzy:
Choi Y; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Santhireswaran A; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Chu C; Women's College Hospital, Toronto, Ontario, Canada.
Suda KJ; Center for Health Equity Research and Promotion, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Hernandez I; University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California, USA.
Magnani JW; Center for Health Equity Research and Promotion, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Tadrous M; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada .; Women's College Hospital, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 Jan 27; Vol. 13 (1), pp. e068233. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Hypertension*/drug therapy
Humans ; Valsartan/therapeutic use ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Tetrazoles/therapeutic use
Czasopismo naukowe
Tytuł:
Behavioural Economics to Improve Antihypertensive Therapy Adherence (BETA): protocol for a pilot randomised controlled trial in Los Angeles.
Autorzy:
Ebinger JE; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Ghai I; Frederick S. Pardee RAND Graduate School, RAND Corporation, Santa Monica, California, USA .
Barajas D; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Vallejo R; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Blyler CA; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Morales M; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Garcia N; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Joung S; Smidt Heart Institute, Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Palimaru A; RAND Corporation, Santa Monica, California, USA.
Linnemayr S; RAND Corporation, Santa Monica, California, USA.
Pokaż więcej
Źródło:
BMJ open [BMJ Open] 2023 Jan 25; Vol. 13 (1), pp. e066101. Date of Electronic Publication: 2023 Jan 25.
Typ publikacji:
Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Antihypertensive Agents*/therapeutic use
Economics, Behavioral*
Adult ; Humans ; Los Angeles ; Pilot Projects ; Medication Adherence ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Dissecting the potential mechanism of antihypertensive effects of RVPSL on spontaneously hypertensive rats via widely targeted kidney metabolomics.
Autorzy:
Yu Z; School of Food Science and Engineering, Hainan University, Haikou, PR China.
Wang L; College of Food Science and Engineering, Bohai University, Jinzhou, PR China.
Wu S; Laboratory of Nutrition and Functional Food, Jilin University, Changchun, PR China.
Zhao W; School of Food Science and Engineering, Hainan University, Haikou, PR China.
Pokaż więcej
Źródło:
Journal of the science of food and agriculture [J Sci Food Agric] 2023 Jan 15; Vol. 103 (1), pp. 428-436. Date of Electronic Publication: 2022 Aug 10.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/pharmacology
Hypertension*/drug therapy
Rats ; Animals ; Rats, Inbred SHR ; Arachidonic Acid ; 3-Hydroxybutyric Acid ; Metabolomics ; Kidney ; Blood Pressure ; Biomarkers ; Serine ; Thyronines ; Tyramine ; Citric Acid ; Carbon ; Tyrosine
Czasopismo naukowe
Tytuł:
Discovery and biosynthesis of karnamicins as angiotensin converting enzyme inhibitors.
Autorzy:
Yu Z; State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, 611137, Chengdu, China.; Heilongjiang Provincial Key Laboratory of Agricultural Microbiology, Northeast Agricultural University, 150030, Harbin, China.
Huang JP; State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, 611137, Chengdu, China.; State Key Laboratory of Phytochemistry and Plant Resources in West China, and CAS Center for Excellence in Molecular Plant Sciences, Kunming Institute of Botany, Chinese Academy of Sciences, 650201, Kunming, China.
Yang J; State Key Laboratory of Phytochemistry and Plant Resources in West China, and CAS Center for Excellence in Molecular Plant Sciences, Kunming Institute of Botany, Chinese Academy of Sciences, 650201, Kunming, China.
Liu C; Heilongjiang Provincial Key Laboratory of Agricultural Microbiology, Northeast Agricultural University, 150030, Harbin, China.; State Key Laboratory of Phytochemistry and Plant Resources in West China, and CAS Center for Excellence in Molecular Plant Sciences, Kunming Institute of Botany, Chinese Academy of Sciences, 650201, Kunming, China.
Yan Y; State Key Laboratory of Phytochemistry and Plant Resources in West China, and CAS Center for Excellence in Molecular Plant Sciences, Kunming Institute of Botany, Chinese Academy of Sciences, 650201, Kunming, China.
Wang L; State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, 611137, Chengdu, China.
Zhao J; Heilongjiang Provincial Key Laboratory of Agricultural Microbiology, Northeast Agricultural University, 150030, Harbin, China.
Chen Y; State Key Laboratory of Phytochemistry and Plant Resources in West China, and CAS Center for Excellence in Molecular Plant Sciences, Kunming Institute of Botany, Chinese Academy of Sciences, 650201, Kunming, China.
Xiang W; Heilongjiang Provincial Key Laboratory of Agricultural Microbiology, Northeast Agricultural University, 150030, Harbin, China. .
Huang SX; State Key Laboratory of Southwestern Chinese Medicine Resources, Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, 611137, Chengdu, China. .; State Key Laboratory of Phytochemistry and Plant Resources in West China, and CAS Center for Excellence in Molecular Plant Sciences, Kunming Institute of Botany, Chinese Academy of Sciences, 650201, Kunming, China. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Jan 13; Vol. 14 (1), pp. 209. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Angiotensin-Converting Enzyme Inhibitors*/pharmacology
Antihypertensive Agents*
Molecular Docking Simulation ; Pyridines ; Mixed Function Oxygenases
Czasopismo naukowe
Tytuł:
The antihypertensive effect of remote ischemic conditioning in spontaneously hypertensive rats.
Autorzy:
Li X; Department of Neurology, Aerospace center Hospital, Beijing, China.; Beijing Institute of Brain Disorder, Capital Medical University, Beijing, China.
Ren C; Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuan Wu Hospital, Capital Medical University, Beijing, China.
Li S; Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuan Wu Hospital, Capital Medical University, Beijing, China.
Zhao W; Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuan Wu Hospital, Capital Medical University, Beijing, China.
Wang P; Department of Neurology, Aerospace center Hospital, Beijing, China.
Ji X; Beijing Institute of Brain Disorder, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2023 Jan 12; Vol. 13, pp. 1093262. Date of Electronic Publication: 2023 Jan 12 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antihypertensive Agents*
Hypertension*
Rats ; Animals ; Rats, Inbred SHR ; Rats, Wistar ; Tumor Necrosis Factor-alpha ; Interleukin-6 ; Rats, Inbred WKY
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz